TrialJournal of diabetes2019

Efficacy and safety of lixisenatide as add-on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal-O Study.

George E Dailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.